{"id":1068263,"date":"2022-06-18T01:44:11","date_gmt":"2022-06-18T05:44:11","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/connect-biopharma-announces-receipt-of-nasdaq-deficiency-notice-regarding-minimum-bid-price-requirement\/"},"modified":"2024-08-18T11:45:05","modified_gmt":"2024-08-18T15:45:05","slug":"connect-biopharma-announces-receipt-of-nasdaq-deficiency-notice-regarding-minimum-bid-price-requirement","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/connect-biopharma-announces-receipt-of-nasdaq-deficiency-notice-regarding-minimum-bid-price-requirement.php","title":{"rendered":"Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement"},"content":{"rendered":"<p><![CDATA[SAN DIEGO, CA and TAICANG, SUZHOU, China, June  17, 2022  (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (\"Connect Biopharma\" or the \u201cCompany\u201d) announced on June 16, 2022, Connect Biopharma Holdings Limited (the \u201cCompany\u201d) received a letter from the Listings Qualifications Department of the Nasdaq Stock Market LLC (\u201cNasdaq\u201d) indicating that, for the last thirty consecutive business days, the bid price for the Company\u2019s American Depositary Shares (\u201cADSs\u201d) had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5550(a)(2).]]><\/p>\n<p>Read the original:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/06\/17\/2464907\/0\/en\/Connect-Biopharma-Announces-Receipt-of-NASDAQ-Deficiency-Notice-Regarding-Minimum-Bid-Price-Requirement.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement\">Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the original: Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/connect-biopharma-announces-receipt-of-nasdaq-deficiency-notice-regarding-minimum-bid-price-requirement.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068263","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068263"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068263"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068263\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068263"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068263"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}